Operational consolidation and cost control delivered GBP 8 million in savings, with reproductive healthcare and consumables driving 26% year-on-year growth. Underlying gross margin exceeded 60%, and cash reserves remain strong, supporting continued R&D investment.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.